Ieq Capital LLC grew its position in CVS Health Corporation (NYSE:CVS – Free Report) by 18.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,415 shares of the pharmacy operator’s stock after purchasing an additional 36,631 shares during the period. Ieq Capital LLC’s holdings in CVS Health were worth $19,744,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of CVS. Focus Advisor Solutions LLC increased its position in CVS Health by 151.3% during the 3rd quarter. Focus Advisor Solutions LLC now owns 15,685 shares of the pharmacy operator’s stock worth $1,344,000 after purchasing an additional 9,443 shares in the last quarter. Checchi Capital Advisers LLC raised its holdings in CVS Health by 1.7% in the third quarter. Checchi Capital Advisers LLC now owns 8,276 shares of the pharmacy operator’s stock valued at $709,000 after buying an additional 135 shares during the period. Boston Partners raised its holdings in CVS Health by 28.6% in the third quarter. Boston Partners now owns 2,614,590 shares of the pharmacy operator’s stock valued at $224,044,000 after buying an additional 581,007 shares during the period. OneAscent Financial Services LLC lifted its position in CVS Health by 26.1% during the third quarter. OneAscent Financial Services LLC now owns 8,026 shares of the pharmacy operator’s stock valued at $688,000 after buying an additional 1,661 shares in the last quarter. Finally, Meeder Asset Management Inc. grew its stake in CVS Health by 3.5% during the third quarter. Meeder Asset Management Inc. now owns 57,060 shares of the pharmacy operator’s stock worth $4,889,000 after buying an additional 1,955 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.
Analysts Set New Price Targets
CVS has been the subject of several recent research reports. Evercore reissued an “outperform” rating on shares of CVS Health in a research report on Wednesday, November 4th. Wells Fargo & Company reduced their target price on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a report on Thursday, November 12th. JPMorgan Chase & Co. lifted their target price on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. UBS Group decreased their price target on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating for the company in a research report on Thursday, November 5th. Finally, TD Cowen reiterated a “buy” rating on shares of CVS Health in a report on Wednesday, November 4th. Twenty-three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $107.33.
Get Our Latest Report on CVS Health
CVS Health Trading Up 1.0%
Shares of CVS opened at $80.83 on Friday. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The stock has a 50-day moving average price of $88.42 and a 200 day moving average price of $89.29. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85. The company has a market capitalization of $103.42 billion, a P/E ratio of 9.41, a P/E/G ratio of 0.77 and a beta of 0.58.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The company had revenue of $108.40 billion for the quarter, compared to the consensus estimate of $104.72 billion. During the same period in the previous year, the business earned $1.60 EPS. CVS Health’s revenue for the quarter was up 5.4% compared to the same quarter last year. Sell-side analysts forecast that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a dividend of $0.6650 per share. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 30.97%.
Insider Activity
In related news, EVP Prem Shah purchased 23,855 shares of the company’s stock in a transaction that occurred on Friday, November 6th. The stock was acquired at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the completion of the purchase, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.85% of the company’s stock.
Recent CVS Health Headlines
Investors following CVS have been watching these headlines:
- Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
- Neutral Sentiment: CVS also announced winners of a youth soccer contest, with grants for their nonprofit organizations. This is brand and community outreach rather than a material financial catalyst. Article: CVS Pharmacy names Home Team Heroes contest winners
- Negative Sentiment: A local pharmacist activist said the upcoming CVS split would not benefit patients or workers. This reflects criticism of the plan, but the report does not establish broader opposition or quantify any financial impact. Article: Pharmacist activist criticizes upcoming CVS split
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Read More
- Five stocks we like better than CVS Health
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
